{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:08:47Z","timestamp":1782443327203,"version":"3.54.5"},"reference-count":53,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2016,8,29]],"date-time":"2016-08-29T00:00:00Z","timestamp":1472428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:p>Human papillomavirus (HPV) contributes to the most common sexually transmitted infections, with repeated and persistent infection with particular types causing disease in both men and women. Infection with low\u2010risk HPV types can lead to genital warts and benign lesions of the oral cavity, while high\u2010risk types can cause various HPV\u2010related malignancies. The incidence of head and neck cancers has been rising in the past number of decades mostly due to oropharyngeal cancer linked to HPV infection. HPV vaccination has been shown to be effective for cervical and other anogenital HPV\u2010related cancers, and there is significant potential for HPV vaccination to prevent oropharyngeal cancers, given that the HPV types implicated in this disease can be protected against by the HPV vaccine. Few countries have implemented a universal HPV vaccination programme for males and females, with many countries arguing that female\u2010only vaccination programmes protect males via herd immunity and that men who have sex with men will be protected via targeted vaccination programmes. We argue these may be limited in their effectiveness. We propose that the most effective, practical, ethical and potentially cost\u2010effective solution is universal HPV vaccination that might lead to control of HPV\u2010related diseases in men and women alike.<\/jats:p>","DOI":"10.1111\/odi.12562","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T07:47:49Z","timestamp":1470383269000},"page":"726-730","source":"Crossref","is-referenced-by-count":27,"title":["Human papillomavirus (HPV): making the case for \u2018Immunisation for All\u2019"],"prefix":"10.1111","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2198-3731","authenticated-orcid":false,"given":"G","family":"Prue","sequence":"first","affiliation":[{"name":"School of Nursing and Midwifery Queen's University Belfast Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lawler","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research and Cell Biology Queen's University Belfast Belfast UK"},{"name":"European Cancer Concord Leeds UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Baker","sequence":"additional","affiliation":[{"name":"HPV Action Rugby UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Warnakulasuriya","sequence":"additional","affiliation":[{"name":"King's College London London UK"},{"name":"WHO Collaborating Centre for Oral Cancer London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,8,29]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.12.007"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2011.08.002"},{"key":"e_1_2_9_4_1","unstructured":"Australia Government Department of Health(2014).Human papillomavirus. Immunise Australia Program."},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv302"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2016"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/2051013614557476"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2013-100583"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.12968\/bjsn.2013.8.2.71"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30099-7"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.031"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2011.12.013"},{"key":"e_1_2_9_13_1","unstructured":"Canadian Immunization Committee(2014).Recommendations for human papillomavirus immunization programs.Public Analysis CMAJ 5 Health Agency of Canada:Ottawa. Available at:http:\/\/publications.gc.ca\/collections\/collection_2014\/aspc-phac\/HP40-107-2014-eng.pdf[accessed on 12 April 2016]."},{"key":"e_1_2_9_14_1","unstructured":"Cancer Research UK(2016)What is the HPV virus?Available at:http:\/\/www.cancerresearchuk.org\/about-cancer\/cancers-in-general\/cancer-questions\/what-is-the-hpv-virus[accessed on 22 July 2016]."},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268815002198"},{"key":"e_1_2_9_16_1","unstructured":"Centers for Disease Control and Prevention(2016)VFC Program. Available at:http:\/\/www.cdc.gov\/features\/vfcprogram\/[accessed on 28 June 2016]."},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.4596"},{"key":"e_1_2_9_18_1","first-page":"1","article-title":"Quadrivalent vaccine\u2010targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study","volume":"6","author":"Chow EPF","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"e_1_2_9_19_1","unstructured":"ColbertY(2015)HPV vaccine for Nova Scotia boys called \u2018groundbreaking.\u2019 CBC News 2015 Apr. 13. Available at:www.cbc.ca\/news\/canada\/nova-scotia\/hpv-vaccine-for-nova-scotia-boys-called-groundbreaking-1.3031169[accessed on 7 April 2016]."},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)71073-4"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065497"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1086\/507432"},{"key":"e_1_2_9_23_1","unstructured":"European Centre for Disease Prevention and Control (ECDC)(2016)Vaccine schedule. Recommended immunisations for human papillomavirus infection. Available at:http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx[accessed on 27 April 2016]."},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210"},{"key":"e_1_2_9_25_1","unstructured":"Food and Drug Administration.Highlights of prescribing information. Gardasil (human papillomavirus quadrivalent [types 6 11 16 and 18]).Silver Spring MD:Food and Drug Administration;2011. Available at:http:\/\/www.fda.gov\/downloads\/biologicsbloodvaccines\/vaccines\/approvedproducts\/ucm111263.pdf[accessed on 28 June 2016]"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.055"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23764"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0151"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909537"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29111"},{"key":"e_1_2_9_31_1","unstructured":"GrantK(2015)Nova Scotia to include boys in HPV vaccination schedule.Globe and Mail:Toronto. Available at:www.theglobeandmail.com\/life\/health-and-fitness\/health\/nova-scotia-to-include-boys-in-hpv-vaccination-schedule\/article23886885(accessed on 2 February 2016]."},{"key":"e_1_2_9_32_1","first-page":"1","article-title":"Trends in genital warts and genital herpes diagnoses in the United Kingdom","volume":"1","author":"Health Protection Agency","year":"2007","journal-title":"Health Protection Report"},{"key":"e_1_2_9_33_1","unstructured":"Human papillomavirus (HPV) vaccine.Gouvernement du Qu\u00e9bec:Quebec;2016. Available at:http:\/\/sante.gouv.qc.ca\/en\/conseils-et-prevention\/vaccin-contre-les-infections-par-les-virus-du-papillome-humain-vph[accessed on 12 April 2016]."},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318253a2d1"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c2512"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-15-0406"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13561-015-0054-6"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0551"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.06.015"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-13"},{"key":"e_1_2_9_41_1","unstructured":"Manitoba's immunization program: vaccines offered free\u2010of charge (eligibility criteria for publicly\u2010funded vaccines).Communicable Disease Control. Manitoba Health Healthy Living and Seniors:Winnipeg;2015. Available at:www.gov.mb.ca\/health\/publichealth\/cdc\/vaccineeligibility.html[accessed on 12 April 2016]."},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-10"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010971"},{"key":"e_1_2_9_44_1","unstructured":"Public Health Englanddata (2013). Available at:https:\/\/www.gov.uk\/government\/publications\/annual-hpv-vaccine-coverage-2012-to-2013-by-pct-and-sha[accessed on 19 February 2014]"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2014-100896"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70230-8"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-1050-2_13"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2015.09.013"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.150451"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101048"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/488S10a"},{"key":"e_1_2_9_52_1","unstructured":"Switzerland's Federal Public Health Office maladies transmissibles Vaccination contre les HPV: recommandation de vaccination compl\u00e9mentaire pour les gar\u00e7ons et jeunes hommes \u00e2g\u00e9s de 11 \u00e0 26 ans. (2015) bulletin 10 2 mar 2015 141 \u2013 150 Office f\u00e9d\u00e9ral de la sant\u00e9 publique (OFSP)."},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/codi.12553"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit626"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fodi.12562","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fodi.12562","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/odi.12562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T18:17:00Z","timestamp":1695493020000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/odi.12562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,29]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1111\/odi.12562"],"URL":"https:\/\/doi.org\/10.1111\/odi.12562","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,29]]}}}